# Ted Tan

> Ted Tan is a seed investor at Enterprise Singapore backing Medical and Nutrition. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Enterprise Singapore](https://shizune.co/investors/profile/enterprise-singapore)
- Total investments: 3
- Last investment: Jul 2024
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ted-tan-2308534

Ted Tan is a seed investor at Enterprise Singapore focused on Medical and Nutrition. Mr. Ted Tan has over 30 years of public and private sector experience in policy making, programme development, leadership, coaching and mentoring, governance, and risk management.Formerly the Deputy CEO of Enterprise Singapore, an agency under the Singapore Ministry of Trade and Industry, Mr. Tan stood down in September 2021 and is now anEnterprise Fellow of Enterprise Singapore. Additionally, Mr. Tan is the Operating Partner of Heliconia Capital Management, a wholly owned subsidiary of Temasek Holdings that provides growth capital for SMEs.Mr. Tan is Chairman of Singapore based molecular diagnostics developer INEX Innovate, a Board Director of Singapore SGX Mainboard-listed Q&M Dental Group, and Board Director of China Life Insurance (Singapore) – a subsidiary of China Life Insurance Group, a Fortune 500 company. He is also the Chairman of IPI that catalyses innovation and Board Director of SEEDS Capital that invests in innovative startups.Mr. Tan has been appointed an Adjunct Associate Professor of the Nanyang Business School at Singapore’s Nanyang Technological University.In 2012, Mr. Tan was awarded the Public Administration Medal (Silver) by the Singapore government.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Nutrition | 1 | 33% |
| Health Care | 1 | 33% |
| Therapeutics | 1 | 33% |
| Biotechnology | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| The Gentle Group | SilverConnect is a medical nutrition startup creating specialized food solutions for people with dysphagia. Dysphagia, or the difficulty to swallow, is more common in older people and often results from nerve or muscle problems. | $2M | Venture - Series Unknown | Jul 08, 2024 |  |
| Ligature Therapeutics | Ligature Therapeutics is an early-stage biotechnology company that develops small molecule “protein degrader” therapeutics.Ligature Therapeutics is an early-stage drug discovery company that takes a novel approach towards developing small molecules for targeted protein degradation to treat intractable diseases. Ligature Therapeutics was foundedby doctors Alvin Hung, Thomas Keller, and Congbao Kang with initial investment from Lightstone Singapore, a Singapore-focused venture fund founded in 2016 by Lightstone Ventures. | $6M | Seed | Jan 04, 2021 |  |
| The Gentle Group | SilverConnect is a medical nutrition startup creating specialized food solutions for people with dysphagia. Dysphagia, or the difficulty to swallow, is more common in older people and often results from nerve or muscle problems. |  | Seed | Jun 22, 2020 |  |

3 of 3 investments shown.

## Co-investors
- [OCTAVE Capital](https://shizune.co/investors/profile/heritas-capital-management) — VC Fund, 2 deals together
- [AVA Angels](https://shizune.co/investors/profile/ava-angels) — VC Fund, 1 deal together
- [Lightstone Ventures](https://shizune.co/investors/profile/lightstone-ventures) — VC Fund, 1 deal together

## About Enterprise Singapore

VC Fund · Singapore, Singapore

Enterprise Singapore is a government agency that supports enterprise development.The company works with committed companies to build capabilities, innovate and internationalize. Enterprise Singapore also supports the growth of Singapore as a hub for global trading and startups. As the national standards and accreditation body, the companycontinues to build trust in Singapore’s products and services through quality and standards.To enable businesses navigate today’s enterprise landscape, Enterprise Singapore adopts a company-centric approach. Enterprise Singapore do so, by providing programmes and support catered to your company’s stage of growth, the industry you are in, and the overseas markets of your interest.

5 contacts available at Enterprise Singapore.

| Name | Title | Profile |
| --- | --- | --- |
| Ted Tan | Deputy Chief Executive Officer | https://shizune.co/investors/profile/ted-tan |
| Bernice Tay | Director of Food Manufacturing | https://shizune.co/investors/profile/bernice-tay |
| Mark Yong | Building Façade Inspection Unmanned Aerial Systems Working Group; UAS Manufacturing Working Group | https://shizune.co/investors/profile/mark-yong |
| NEO Kok Beng | Final Evaluation Panel, TECS | https://shizune.co/investors/profile/a-prof-neo-kok-beng |
| Png Cheong Boon | Chief Executive Officer | https://shizune.co/investors/profile/png-cheong-boon |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ted Tan invest in?

Ted Tan invests primarily in Medical, Nutrition and Health Care startups, most often at Seed and Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ted Tan last invest?

The most recent investment recorded for Ted Tan closed in Jul 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co